Gan Suay Hong, KhinMar Kyi Win, Ang Li Wei, Lim Leo K Y, Sng Li Hwei, Wang Yee Tang, Chee Cynthia B E
Tuberculosis Control Unit, Tan Tock Seng Hospital, Singapore.
National Centre for Infectious Diseases, Singapore.
Open Forum Infect Dis. 2021 Jun 27;8(7):ofab340. doi: 10.1093/ofid/ofab340. eCollection 2021 Jul.
Previously treated (ie, recurrent) tuberculosis (TB) cases account for approximately 7%-8% of incident TB globally and in Singapore. Molecular fingerprinting has enabled the differentiation of these patients into relapsed or reinfection cases.
Patient demographics, disease characteristics, and treatment information were obtained from the national TB notification registry and TB Control Unit. We performed a retrospective, case-control study to evaluate factors associated with recurrent TB disease in Singapore citizens and permanent residents with culture-positive TB from 2006 to 2013 and who developed a second episode of culture-positive TB up to 2016 using multivariable logistic regression analyses.
Ninety-one cases with culture-positive first and recurrent TB disease episodes were identified. Recurrent TB was associated with age ≥60 years (adjusted odds ratio [aOR], 1.98 [95% confidence interval {CI}, 1.09-3.61), male sex (aOR, 2.29 [95% CI, 1.22-4.51]), having concomitant pulmonary and extrapulmonary TB (aOR, 3.10 [95% CI, 1.59-6.10]) and extrapulmonary TB alone (aOR, 3.82 [95% CI, 1.12-13.31]), and was less likely in non-Malays (aOR, 0.52 [95% CI, .27-.99]). DNA fingerprinting results for both episodes in 49 cases differentiated these into 28 relapsed and 21 reinfection cases. Relapse was associated with having concomitant pulmonary and extrapulmonary TB (aOR, 9.24 [95% CI, 2.50-42.42]) and positive sputum acid-fast bacilli smear (aOR, 3.95 [95% CI, 1.36-13.10]).
Relapse and reinfection contributed to 57% and 43%, respectively, of recurrent TB in Singapore. Our study highlights the underappreciated association of concomitant pulmonary and extrapulmonary TB as a significant risk factor for disease relapse.
既往接受过治疗(即复发性)的结核病(TB)病例在全球及新加坡的新发结核病中约占7%-8%。分子指纹识别技术已能将这些患者区分为复发或再感染病例。
从国家结核病通报登记处和结核病控制部门获取患者的人口统计学资料、疾病特征及治疗信息。我们进行了一项回顾性病例对照研究,以评估2006年至2013年期间痰培养阳性的新加坡公民和永久居民中与复发性结核病相关的因素,这些患者在2016年前出现了第二次痰培养阳性的结核病发作,并采用多变量逻辑回归分析。
共识别出91例痰培养阳性的初发和复发性结核病发作病例。复发性结核病与年龄≥60岁(调整优势比[aOR],1.98[95%置信区间{CI},1.09-3.61])、男性(aOR,2.29[95%CI,1.22-4.51])、合并肺内和肺外结核病(aOR,3.10[95%CI,1.59-6.10])以及仅肺外结核病(aOR,3.82[95%CI,1.12-13.31])相关,而非马来人患复发性结核病的可能性较小(aOR,0.52[95%CI,0.27-0.99])。49例患者两次发作的DNA指纹识别结果将其分为28例复发和21例再感染病例。复发与合并肺内和肺外结核病(aOR,9.24[95%CI,2.50-42.42])及痰涂片抗酸杆菌阳性(aOR,3.95[95%CI,1.36-13.10])相关。
在新加坡,复发和再感染分别占复发性结核病的57%和43%。我们的研究强调了合并肺内和肺外结核病作为疾病复发的一个重要危险因素这一未得到充分重视的关联。